Masatoshi Hasegawa Selected Research

Masatoshi Hasegawa Research Topics

Disease

31	Prostatic Neoplasms (Prostate Cancer) 09/2022 - 01/2009
23	Neoplasms (Cancer) 01/2022 - 09/2002
11	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2004
10	Pancreatic Neoplasms (Pancreatic Cancer) 02/2019 - 11/2009
10	Lymphoma (Lymphomas) 10/2014 - 01/2002
7	Lower Urinary Tract Symptoms 01/2022 - 12/2014
5	Carcinoma (Carcinomatosis) 08/2006 - 01/2004
3	Hypoxia (Hypoxemia) 01/2022 - 11/2002
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2006 - 10/2004
2	Second Primary Neoplasms (Neoplasms, Second) 09/2022 - 09/2006
2	Overactive Urinary Bladder (Overactive Bladder) 01/2022 - 08/2017
2	Margins of Excision 06/2019 - 10/2014
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2016 - 03/2006
2	Lung Neoplasms (Lung Cancer) 05/2015 - 05/2008
2	Squamous Cell Carcinoma of Head and Neck 04/2015 - 07/2013
2	Brain Neoplasms (Brain Tumor) 01/2014 - 01/2006
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2012 - 01/2006
2	Glioblastoma (Glioblastoma Multiforme) 05/2011 - 02/2009
2	Fibrosis (Cirrhosis) 01/2010 - 03/2006
2	Adenocarcinoma of Lung 05/2008 - 09/2005
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 11/2007 - 09/2003
1	Extranodal NK-T-Cell Lymphoma 10/2022
1	Hypertension (High Blood Pressure) 02/2022
1	Erectile Dysfunction 02/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Obesity 01/2021
1	Insulin Resistance 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Hypercholesterolemia 01/2021
1	Necrosis 07/2020
1	Central Nervous System Diseases (CNS Diseases) 01/2020
1	Vomiting 12/2019
1	Nausea 12/2019
1	Rupture 03/2019
1	Arteriovenous Malformations (Arteriovenous Malformation) 03/2019
1	Skin Diseases (Skin Disease) 01/2019
1	Xeroderma Pigmentosum (Kaposi's Disease) 01/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2019
1	Breast Neoplasms (Breast Cancer) 04/2017
1	Uterine Neoplasms (Uterine Cancer) 01/2016
1	Stress Fractures (Stress Fracture) 01/2016

Drug/Important Bio-Agent (IBA)

5	Iodine-125IBA 01/2019 - 01/2009
4	Prostate-Specific Antigen (Semenogelase)IBA 01/2020 - 10/2011
4	Gemcitabine FDA Link 02/2013 - 11/2009
3	AndrogensIBA 02/2022 - 10/2014
3	Fluorouracil (Carac)FDA LinkGeneric 11/2020 - 11/2009
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2020 - 05/2018
3	Adrenergic Receptors (Adrenergic Receptor)IBA 10/2019 - 12/2014
3	DNA (Deoxyribonucleic Acid)IBA 05/2017 - 05/2011
2	Testosterone (Sustanon)FDA Link 02/2022 - 01/2020
2	GadoliniumIBA 01/2022 - 07/2020
2	AcidsIBA 01/2022 - 09/2020
2	Tamsulosin (Flomax)FDA LinkGeneric 01/2022 - 09/2020
2	silodosin FDA Link 11/2021 - 12/2014
2	naftopidilIBA 11/2021 - 12/2014
2	Antineoplastic Agents (Antineoplastics)IBA 11/2020 - 05/2008
2	Pharmaceutical PreparationsIBA 01/2020 - 11/2010
2	Deoxyglucose (2 Deoxy D glucose)IBA 04/2015 - 04/2012
1	AnthracyclinesIBA 10/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	mirabegronIBA 01/2022
1	protoporphyrin IXIBA 01/2022
1	Uric Acid (Urate)IBA 01/2021
1	Celecoxib (Celebrex)FDA Link 09/2020
1	AmberIBA 09/2020
1	Bevacizumab (Avastin)FDA Link 07/2020
1	Small Cytoplasmic RNAIBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2019
1	PlasticsIBA 02/2019
1	Pyrimidine DimersIBA 01/2019
1	8,5'-cyclo-2'-deoxyadenosineIBA 01/2019
1	purineIBA 01/2019
1	2-(morpholin-4-yl)benzo(h)chromen-4-oneIBA 05/2017
1	AnionsIBA 04/2017
1	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 04/2017
1	Proteins (Proteins, Gene)FDA Link 04/2017
1	Organic Anion TransportersIBA 04/2017
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 04/2017
1	CationsIBA 04/2017
1	Peptides (Polypeptides)IBA 04/2017
1	BoronIBA 03/2016
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2016

Therapy/Procedure

39	Radiotherapy 09/2022 - 01/2002
27	Brachytherapy 09/2022 - 01/2004
10	Therapeutics 10/2022 - 01/2002
9	Drug Therapy (Chemotherapy) 06/2016 - 01/2002
6	Neoadjuvant Therapy 02/2019 - 11/2011
4	Chemoradiotherapy 04/2015 - 07/2005
3	Prostatectomy (Retropubic Prostatectomy) 06/2019 - 10/2014
2	Adjuvant Chemotherapy 09/2018 - 11/2009
2	Pancreatectomy 09/2018 - 06/2016
2	Catheters 06/2016 - 11/2011
2	Salvage Therapy 10/2014 - 09/2003
1	Particle Accelerators 01/2022
1	Stents 02/2019
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2018
1	Vascular Access Devices (Arterial Line) 06/2016
1	Boron Neutron Capture Therapy 03/2016